オメガ3の世界市場：2025年～2032年

世界のオメガ3の市場規模は、2024年に26億4,000万米ドルに達し、2032年には48億5,000万米ドルに達すると予測され、予測期間の2025年～2032年のCAGRは7.92％となる見込みです。

市場拡大の背景には、脳と心臓の健康を増進するために、人間の食生活でオメガ3成分の使用が増加していることがあります。さらに、ヘルスケアと個人の健康に対する消費支出の増加が製品需要を促進すると予測されています。消費者が従来の魚油に代わるものを求めているため、市場は絶えず製品ソースを多様化しています。クリルオイルは、通常の魚油と比較して優れた品質を持つため、最も広く使用されているオメガ3供給源の1つです。

さらに、Aker Biomarine Antarctic ASのような重要な企業は、2021年の同社の収益が証明しているように、製品の提供を増やすために新しい漁船を導入して生産能力の増強に取り組んでいます。発展途上国の政府は、南極オキアミ漁を奨励するために、研究費の提供や革新的な提携の形成など、多くのイニシアチブを開始しており、業界の成長に拍車をかける可能性があります。このような変数が予測期間中の製品需要を促進すると予想されます。

オメガ3、特にEPAとDHAは、適切な成長、開発、健康のために人間の食事に必要です。心臓の健康、関節と炎症の緩和、目の健康、認知機能、妊娠と子供の発達、免疫機能に有益です。オメガ3脂肪酸は、心血管疾患のリスクを軽減することが認められています。心血管疾患による死亡率は最近、世界中で上昇傾向にあります。西サハラ以南のアフリカや南アジアでは、心血管疾患の罹患率が上昇しています。国連人口基金（インド）によると、インドの高齢者の心臓病患者数は2050年までに1,910万人になると予測されています。

インドや中国のように心臓病の有病率が拡大している国は、心臓の健康グッズに対する需要を生み出し、オメガ3製品市場を強化しています。オメガ3脂肪酸は、ドライアイ症候群をはじめとするいくつかの眼科疾患の予防や治療にも役立ちます。研究によると、オメガ3脂肪酸を食事やサプリメントで摂取すると、黄斑変性症や緑内障になる可能性が低くなるといいます。その結果、オメガ3脂肪酸が人間の健康のさまざまな側面にもたらす恩恵は、市場需要を押し上げると予測されています。

世界のオメガ3市場における主な抑制要因の一つは、乱獲問題と環境規制による魚油ベースの原料の不足です。オメガ3生産量の大部分は、アンチョビ、イワシ、サバを含む海洋資源に由来しており、季節変動、地政学的制約、持続可能性の要求の影響を受ける。

たとえば2023年には、アンチョビを原料とする魚油の世界最大の生産国であるペルーが、魚の個体数の減少を理由に禁漁を実施し、オメガ3市場の供給不足と価格不安定を招きました。その結果、メーカーは現在、藻類由来のオメガ3のような代替ソースを探していますが、これらはまだ高価であり、拡大する世界の需要を満たすにはより拡張性が必要です。

当レポートでは、世界のオメガ3市場について調査し、市場の概要とともに、由来別、タイプ別、用途別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第5章 業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 持続可能な分析
• DMIオピニオン

第6章 由来別

• 藻類
• 魚
• オキアミ
• その他

第7章 タイプ別

• ドコサヘキサエン酸（DHA）
• エイコサペンタエン酸（EPA）
• α-リノレン酸（ALA）
• その他

第8章 用途別

• 機能性食品・飲料
  • 植物油
  • シアバター
• 栄養補助食品
• 乳児用ミルク
• 化粧品
• 動物栄養
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市場ポジショニング/シェア分析
• 合併と買収の分析

第11章 企業プロファイル

• Polaris
• Koninklijke DSM NV
• BASF SE
• Corbion NV
• ADM
• Simris Alg AB
• Croda International Plc
• Novotech Nutraceuticals, Inc.
• Source Omega LLC
• Algarithm

第12章 付録

Global Omega-3 Market reached US$ 2.64 billion in 2024 and is expected to reach US$ 4.85 billion by 2032, growing with a CAGR of 7.92% during the forecast period 2025-2032.

The market expansion is due to the increasing use of omega-3 ingredients in the human diet to enhance brain and heart health. Furthermore, rising consumer spending in healthcare and personal well-being is predicted to drive product demand. The market is constantly diversifying its product sources as consumers seek alternatives to traditional fish oil. Krill oil is one of the most extensively used sources of omega-3 because of its superior qualities when compared to regular fish oil.

Furthermore, significant enterprises like as Aker Biomarine Antarctic AS are working on boosting capacity by introducing new catching vessels to increase their product offerings, as evidenced by the company's revenues in 2021. Governments in developing countries are launching a number of initiatives to encourage Antarctic Krill fishing, including providing research money and forming innovative alliances, which could spur industry growth. Such variables are expected to drive the product demand during the forecast period.

Dynamic

Rising Health Benefits of Omega-3

Omega-3s, notably EPA and DHA, are required in the human diet for appropriate growth, development and health. They are beneficial for heart health, joint and inflammation relief, eye health, cognitive function, pregnancy and child development and immune function. Omega-3 fatty acids are recognized to lessen the risk of cardiovascular disease. Cardiovascular disease mortality has recently been on the rise around the world. In Western Sub-Saharan Africa and South Asia, cardiovascular disease rates have risen. According to the United Nations Population Fund (India), the number of instances of heart disease among older adults in India is anticipated to be 19.1 million by 2050.

Countries such as India and China, where the prevalence of heart disease is expanding, create demand for heart health goods, bolstering the omega-3 product market. Omega-3 fatty acids can also help prevent and treat several eye problems, including dry eye syndrome. According to studies, ingesting omega-3 fatty acids, whether in meals or supplements, may lower your chance of getting macular degeneration and glaucoma. As a result, omega-3's benefits in different aspects of human health are projected to boost its market demand.

Supply Chain Constraints and Sustainability Challenges

One of the primary constraints in the global omega-3 market is the scarcity of fish oil-based raw materials due to overfishing issues and environmental regulations. The majority of omega-3 production comes from marine sources including anchovies, sardines and mackerel, which are subject to seasonal changes, geopolitical constraints and sustainability demands.

For example, in 2023, Peru, the world's top producer of anchovy-based fish oil, implemented fishing prohibitions owing to diminishing fish populations, resulting in supply shortages and price instability in the omega-3 market. As a result, manufacturers are now searching for alternate sources like algae-derived omega-3, although these are still more expensive and require more scalability to satisfy expanding worldwide demand.

Segment Analysis

The global omega-3 market is segmented based on source, type, application and region.

DHA in the global market is expected to drive the market.

In 2024, the DHA segment accounted for the largest percentage of global omega-3 market. The segment's growth is due to the increasing use of the product in newborn formulae to improve an infant's overall health. DHA is the most vital and plentiful omega-3 fatty acid in the human diet, contributing to overall body health. DHA is essential for the development and maturation of an infant's brain and vision.

Furthermore, it is commonly utilized in dietary supplements and fortified foods. It is used to treat dementia, ADHD, CAD and type 2 diabetes. Companies create new items to fulfill market demand. For example, in 2022 orlo Nutrition launched a DHA Starter Kit with an algal omega-3 supplement to assist the brain, heart, joints and body systems.

Geographical Penetration

Growing Health Consciousness in Asia-Pacific.

Asia-Pacific is expected to be the fastest growing region in the global omega-3 market. Several reasons fueling the region's growth include expanding consumer health consciousness, an aging population valuing cognitive health and high birth rates, which increase demand for infant nutritional products. Additionally, the popularity of plant-based diets has resulted in an increase in demand for algae-based omega-3 supplements.

Furthermore, other significant players have innovated, such as Daewoong Bio, which developed CRA-TG in June 2024, a combination of the hyperlipidemia medicine rosuvastatin and omega-3 intended at lowering patients' triglyceride levels. This new addition to Daewoong Bio's hyperlipidemia treatment range joins nine other medications, including Atorvastatin Tablets and Oma-TG Soft Capsule. CRA-TG has exhibited better lipid profiles and increased tolerance and stability.

Competitive Landscape

The major global players in the market include Polaris, Koninklijke DSM N.V., BASF SE, Corbion NV, ADM, Simris Alg AB, Croda International Plc, Novotech Nutraceuticals, Inc., Source Omega LLC and Algarithm.

Key Developments

• In January 2024, Ritual introduced the Omega-3 DHA + EPA supplement. It contains 500 mg of omega-3 fatty acids in a 2:1 ratio of DHA and EPA. The oil is sustainably sourced from microalgae in La Foret-Fouesnant, France and processed using unique technique to minimize oxidation, resulting in minimal burp-back.
• In March 2023, Epax announced a $40 million investment in molecular distillation technology to enhance the processing of highly concentrated omega 3.
• In May 2023, Nuseed Global will launch Nuseed Nutriterra, an omega-3-enriched plant-based oil designed for the human nutrition and dietary supplement industries.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than Source generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Source
• 3.2. Snippet by Type
• 3.3. Snippet by Application
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Health Benefits of Omega-3
  • 4.1.2. Restraints
    • 4.1.2.1. Supply Chain Constraints and Sustainability Challenges
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Sustainable Analysis
• 5.6. DMI Opinion

6. By Source

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 6.1.2. Market Attractiveness Index, By Source
• 6.2. Algae*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Fish
• 6.4. Krill
• 6.5. Others

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Docosahexaenoic Acid (DHA)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Eicosapentaenoic Acid (EPA)
• 7.4. Alpha-Linolenic Acid (ALA)
• 7.5. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Functional Foods and Beverage*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.2.3. Vegetable Oil
  • 8.2.4. Shea Butter
• 8.3. Dietary Supplements
• 8.4. Infant Formula
• 8.5. Cosmetics
• 8.6. Animal Nutrition
• 8.7. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Polaris*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Koninklijke DSM N.V.
• 11.3. BASF SE
• 11.4. Corbion NV
• 11.5. ADM
• 11.6. Simris Alg AB
• 11.7. Croda International Plc
• 11.8. Novotech Nutraceuticals, Inc.
• 11.9. Source Omega LLC
• 11.10. Algarithm

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us